Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Non Operating Income (2022 - 2025)

CervoMed (CRVO) has disclosed Non Operating Income for 9 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 156.32% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$785439.0 through Dec 2025, down 129.49% year-over-year, with the annual reading at -$8327.0 for FY2025, 100.43% down from the prior year.
  • Non Operating Income hit -$1.1 million in Q4 2025 for CervoMed, down from $317560.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $4.8 million in Q3 2023 to a low of -$1.1 million in Q4 2025.
  • Historically, Non Operating Income has averaged $479337.8 across 4 years, with a median of -$111.5 in 2022.
  • Biggest five-year swings in Non Operating Income: skyrocketed 5429445.45% in 2023 and later crashed 4052.23% in 2025.
  • Year by year, Non Operating Income stood at -$588577.0 in 2022, then skyrocketed by 99.9% to -$600.0 in 2023, then skyrocketed by 323458.83% to $1.9 million in 2024, then tumbled by 156.32% to -$1.1 million in 2025.
  • Business Quant data shows Non Operating Income for CRVO at -$1.1 million in Q4 2025, $317560.0 in Q3 2025, and -$10256.0 in Q2 2025.